Blocking a key receptor may curb immunotherapy-related liver damage
Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising
<p>Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising </p>